MoleculA products are licensed under U.S. and international patent rights owned by the Carnegie Institution of Washington that cover RNA interference.
The Carnegie Institution of Washington granted rights to Molecula to the claims of US Patent Applications 60/068562, 09/215257, PCT/US98/27233, Fire et. al #6,506,559.